Knockdown of PLK3 is associated with downregulation of the critical regulators of epithelial-mesenchymal transition and prognosticators of worse clinical outcomes in patients with PCa such as SNAI2 and MMP11 (Figure 6D). This evidence concerns the gene PLK3 and posterior cortical atrophy.